Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators
- L. Broad, R. Zwart, E. Sher
- Biology, ChemistryJournal of Pharmacology and Experimental…
- 1 September 2006
Three novel (2-amino-5-keto)thiazole compounds that act as selective potentiators of nicotinic acetylcholine receptors are discovered, which should help in clarifying the potential therapeutic utility of selective nAChR modulation for the treatment of central nervous system disorders.
Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.
- P. Astles, S. Baker, J. Boot, L. Broad, C. Dell, M. Keenan
- Biology, ChemistryCurrent Drug Targets - CNS & Neurological…
- 31 July 2002
The first 1000 fold selective low molecular weight ligands from the AstraZeneca group are described and the first subtype specific channel modulators are commented on.
Innovative drug development for headache disorders: glutamate
- Kirk W. Johnson, E. Nisenbaum, D. Bleakman
- Medicine
- 1 August 2008
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia
- M. O'Neill, T. Murray, Jaipal Singh
- Biology, MedicineBrain Research
- 21 July 2000
Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo.
- M. O'Neill, C. Bath, D. Bleakman
- BiologyEuropean Journal of Pharmacology
- 6 August 1997
Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia
- C. Hicks, M. Ward, M. O'Neill
- Chemistry, BiologyBrain Research
- 20 February 1999
Identification of a novel chemical series that blocks interleukin-1-stimulated metalloprotease activity in chondrocytes.
- S. Chandrasekhar, A. Harvey, C. Dell, S. J. Ambler, C. Smith
- BiologyJournal of Pharmacology and Experimental…
- 1 June 1995
This class of compounds represents one of very few that are known to block the synthesis, rather than the activity, of matrix-degrading metalloproteases and thus may be beneficial in preventing the cartilage destruction associated with several degenerative diseases of the articular joint.
Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.
- T. Wiernicki, J. Bean, J. Singh
- Biology, ChemistryJournal of Pharmacology and Experimental…
- 1 September 1996
It is demonstrated that naphthopyrans LY290181 and LY290293 are potent inhibitors of smooth muscle cell proliferation in vitro and that they produce substantial reduction in arterial intimal thickening in a balloon injury model when administered systemically.
Oxidative 5-endo cyclization of enamides mediated by ceric ammonium nitrate.
- A. Clark, C. Dell, John M. McDonagh, J. Geden, Peter Mawdsley
- ChemistryOrganic Letters
- 9 May 2003
The methodology was used to synthesize the basic heterocyclic ring fragments of the natural products L-755,807, Quinolacticin C, and PI-091.
...
...